Companies House 07533771 2025-02-28 2025-02-28 2024-03-01 false iso4217:GBP xbrli:pure 07533771 2023-03-01 2024-02-29 07533771 2025-02-28 07533771 2024-03-01 2025-02-28 07533771 2024-02-29 07533771 curr:PoundSterling 2024-03-01 2025-02-28 07533771 uk-bus:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 07533771 uk-bus:FRS102 2024-03-01 2025-02-28 07533771 uk-bus:AuditExempt-NoAccountantsReport 2024-03-01 2025-02-28 07533771 uk-bus:FullAccounts 2024-03-01 2025-02-28 07533771 uk-bus:RegisteredOffice 2024-03-01 2025-02-28 07533771 uk-bus:Director1 2024-03-01 2025-02-28 07533771 uk-bus:Director2 2024-03-01 2025-02-28 07533771 uk-bus:Director3 2024-03-01 2025-02-28 07533771 uk-bus:Director4 2024-03-01 2025-02-28 07533771 uk-bus:Director5 2024-03-01 2025-02-28 07533771 uk-bus:Director6 2024-03-01 2025-02-28 07533771 uk-bus:Director7 2024-03-01 2025-02-28 07533771 uk-bus:Director8 2024-03-01 2025-02-28 07533771 uk-bus:Director9 2024-03-01 2025-02-28 07533771 uk-bus:Director10 2024-03-01 2025-02-28 07533771 uk-bus:Director11 2024-03-01 2025-02-28 07533771 uk-bus:Director12 2024-03-01 2025-02-28 07533771 uk-bus:Director13 2024-03-01 2025-02-28 07533771 uk-bus:Director14 2024-03-01 2025-02-28 07533771 uk-bus:Director15 2024-03-01 2025-02-28 07533771 uk-bus:Director16 2024-03-01 2025-02-28 07533771 uk-bus:Director17 2024-03-01 2025-02-28 07533771 uk-bus:Director18 2024-03-01 2025-02-28 07533771 uk-bus:Director19 2024-03-01 2025-02-28 07533771 uk-bus:Director20 2024-03-01 2025-02-28 07533771 uk-bus:Director21 2024-03-01 2025-02-28 07533771 uk-bus:CompanySecretary1 2024-03-01 2025-02-28 07533771 core:AfterOneYear 2025-02-28 07533771 core:AfterOneYear 2024-02-29 07533771 core:WithinOneYear 2025-02-28 07533771 core:WithinOneYear 2024-02-29 07533771 core:WithinOneYear 2024-03-01 2025-02-28 07533771 core:AfterOneYear 2025-02-28 07533771 core:AfterOneYear 2024-02-29 07533771 core:AfterOneYear 2024-03-01 2025-02-28 07533771 core:ShareCapital 2025-02-28 07533771 core:ShareCapital 2024-02-29 07533771 core:SharePremium 2025-02-28 07533771 core:SharePremium 2024-02-29 07533771 core:OtherReservesSubtotal 2025-02-28 07533771 core:OtherReservesSubtotal 2024-02-29 07533771 core:RevaluationReserve 2025-02-28 07533771 core:RevaluationReserve 2024-02-29 07533771 core:RetainedEarningsAccumulatedLosses 2025-02-28 07533771 core:RetainedEarningsAccumulatedLosses 2024-02-29 07533771 1 2024-03-01 2025-02-28 07533771 2 2024-03-01 2025-02-28 07533771 3 2024-03-01 2025-02-28 07533771 core:LandBuildings 2024-03-01 2025-02-28 07533771 core:LandBuildings 2025-02-28 07533771 core:LandBuildings 2023-03-01 2024-02-29 07533771 core:LandBuildings 2024-02-29 07533771 core:PlantMachinery 2024-03-01 2025-02-28 07533771 core:PlantMachinery 2025-02-28 07533771 core:PlantMachinery 2023-03-01 2024-02-29 07533771 core:PlantMachinery 2024-02-29 07533771 core:FurnitureFittingsToolsEquipment 2024-03-01 2025-02-28 07533771 core:FurnitureFittingsToolsEquipment 2025-02-28 07533771 core:FurnitureFittingsToolsEquipment 2023-03-01 2024-02-29 07533771 core:FurnitureFittingsToolsEquipment 2024-02-29 07533771 core:OfficeEquipment 2024-03-01 2025-02-28 07533771 core:OfficeEquipment 2025-02-28 07533771 core:OfficeEquipment 2023-03-01 2024-02-29 07533771 core:OfficeEquipment 2024-02-29 07533771 core:Vehicles 2024-03-01 2025-02-28 07533771 core:Vehicles 2025-02-28 07533771 core:Vehicles 2023-03-01 2024-02-29 07533771 core:Vehicles 2024-02-29 07533771 core:NetGoodwill 2024-03-01 2025-02-28 07533771 core:NetGoodwill 2025-02-28 07533771 core:NetGoodwill 2023-03-01 2024-02-29 07533771 core:NetGoodwill 2024-02-29 07533771 core:IntangibleAssetsOtherThanGoodwill 2024-03-01 2025-02-28 07533771 core:IntangibleAssetsOtherThanGoodwill 2025-02-28 07533771 core:IntangibleAssetsOtherThanGoodwill 2023-03-01 2024-02-29 07533771 core:IntangibleAssetsOtherThanGoodwill 2024-02-29

# WINZOR PHARMACEUTICALS UK LIMITED

## Company Registration Number:
07533771 (England and Wales)

## Unaudited statutory accounts for the year ended 28 February 2025

## Period of accounts

## Start date: 1 March 2024

## End date: 28 February 2025

# WINZOR PHARMACEUTICALS UK LIMITED

## Contents of the Financial Statements

for the Period Ended 28 February 2025

Directors report |
Profit and loss |
Balance sheet |
Additional notes |
Balance sheet notes |

# WINZOR PHARMACEUTICALS UK LIMITED

Directors' report period ended 28 February 2025

The directors present their report with the financial statements of the company for the period ended 28 February 2025

Principal activities of the company

Pharmaceuticals export

Directors

The directors shown below have held office during the whole of the period from
1 March 2024 to 28 February 2025

Mr Taghlub Al-KASS
DanA AL-KASS
Tara AL-KASS

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
26 June 2025

And signed on behalf of the board by:
Name: Mr Taghlub Al-KASS
Status: Director

# WINZOR PHARMACEUTICALS UK LIMITED

## Profit And Loss Account

for the Period Ended 28 February 2025

| 2025 | 2024
--- | --- | ---
| £ | £
Turnover: | 1,878,884 | 1,578,227
Cost of sales: | ( 1,056,523 ) | ( 765,812 )
Gross profit(or loss): | 822,361 | 812,415
Administrative expenses: | ( 795,977 ) | ( 800,167 )
Operating profit(or loss): | 26,384 | 12,248
Profit(or loss) before tax: | 26,384 | 12,248
Tax: | ( 1,514 ) | ( 2,327 )
Profit(or loss) for the financial year: | 24,870 | 9,921

# WINZOR PHARMACEUTICALS UK LIMITED

## Balance sheet

As at 28 February 2025

| Notes | 2025 | 2024
--- | --- | --- | ---
|  | £ | £
Fixed assets
Tangible assets: | 3 | 804,961 | 804,961
Total fixed assets: |  | 804,961 | 804,961
Current assets
Stocks: | 4 | 338,324 | 488,324
Debtors: | 5 | 424,673 | 254,991
Cash at bank and in hand: |  | 174,714 | 185,758
Total current assets: |  | 937,711 | 929,073
Creditors: amounts falling due within one year: | 6 | ( 60,931 ) | ( 77,163 )
Net current assets (liabilities): |  | 876,780 | 851,910
Total assets less current liabilities: |  | 1,681,741 | 1,656,871
Creditors: amounts falling due after more than one year: | 7 | ( 486,258 ) | ( 486,258 )
Total net assets (liabilities): |  | 1,195,483 | 1,170,613
Capital and reserves
Called up share capital: |  | 99 | 99
Profit and loss account: |  | 1,195,384 | 1,170,514
Total Shareholders' funds: |  | 1,195,483 | 1,170,613

The notes form part of these financial statements

# WINZOR PHARMACEUTICALS UK LIMITED

## Balance sheet statements

For the year ending 28 February 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 26 June 2025
and signed on behalf of the board by:

Name: Mr Taghlub Al-KASS
Status: Director

The notes form part of these financial statements

# WINZOR PHARMACEUTICALS UK LIMITED

## Notes to the Financial Statements

for the Period Ended 28 February 2025

- ## 1. Accounting policies

  Basis of measurement and preparation

  These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

# WINZOR PHARMACEUTICALS UK LIMITED

## Notes to the Financial Statements

for the Period Ended 28 February 2025

- ## 2. Employees

  | 2025 | 2024
  --- | --- | ---
  Average number of employees during the period | 25 | 35

# WINZOR PHARMACEUTICALS UK LIMITED

## Notes to the Financial Statements

for the Period Ended 28 February 2025

## 3. Tangible assets

| Land & buildings | Plant & machinery | Fixtures & fittings | Office equipment | Motor vehicles | Total
--- | --- | --- | --- | --- | --- | ---
Cost | £ | £ | £ | £ | £ | £
At 1 March 2024 | 804,961 |  |  |  |  | 804,961
Additions |  |  |  |  |  |
Disposals |  |  |  |  |  |
Revaluations |  |  |  |  |  |
Transfers |  |  |  |  |  |
At 28 February 2025 | 804,961 |  |  |  |  | 804,961
Depreciation |  |  |  |  |  |
At 1 March 2024 |  |  |  |  |  |
Charge for year |  |  |  |  |  |
On disposals |  |  |  |  |  |
Other adjustments |  |  |  |  |  |
At 28 February 2025 |  |  |  |  |  |
Net book value |  |  |  |  |  |
At 28 February 2025 | 804,961 |  |  |  |  | 804,961
At 29 February 2024 | 804,961 |  |  |  |  | 804,961

# WINZOR PHARMACEUTICALS UK LIMITED

## Notes to the Financial Statements

for the Period Ended 28 February 2025

## 4. Stocks

| 2025 | 2024
--- | --- | ---
| £ | £
Stocks | 338,324 | 488,324
Total | 338,324 | 488,324

# WINZOR PHARMACEUTICALS UK LIMITED

## Notes to the Financial Statements

for the Period Ended 28 February 2025

## 5. Debtors

| 2025 | 2024
--- | --- | ---
| £ | £
Trade debtors | 190,673 | 254,991
Other debtors | 234,000 |
Total | 424,673 | 254,991

# WINZOR PHARMACEUTICALS UK LIMITED

## Notes to the Financial Statements

for the Period Ended 28 February 2025

## 6. Creditors: amounts falling due within one year note

| 2025 | 2024
--- | --- | ---
| £ | £
Trade creditors | 59,417 | 74,836
Taxation and social security | 1,514 | 2,327
Total | 60,931 | 77,163

# WINZOR PHARMACEUTICALS UK LIMITED

## Notes to the Financial Statements

for the Period Ended 28 February 2025

## 7. Creditors: amounts falling due after more than one year note

| 2025 | 2024
--- | --- | ---
| £ | £
Other creditors | 486,258 | 486,258
Total | 486,258 | 486,258